37 results on '"Shin H"'
Search Results
2. Efficacy and safety of micafungin for the prophylaxis of invasive fungal infection during neutropenia in children and adolescents undergoing allogeneic hematopoietic SCT
3. HEPATIC SINUSOIDAL OBSTRUCTION SYNDROME IN PATIENTS WITH MALIGNANT LYMPHOMA UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION: CLINICAL CHARACTERISTICS AND RISK FACTORS: PH-AB102
4. HIGH DOSE CHEMOTHERAPY WITH NITROSOUREA, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR PEDIATRIC LYMPHOMA PATIENTS: A SINGLE CENTER REVIEW: PH-AB022
5. TANDEM HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL RESCUE IN HIGH RISK NEUROBLASTOMA PATIENTS: A SINGLE CENTER EXPERIENCE: PH-P572
6. Tandem high-dose chemotherapy and auto-SCT for malignant brain tumors in children under 3 years of age
7. Peri-engraftment syndrome in allogeneic hematopoietic SCT
8. Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT
9. Comparative survival between younger patients with poor risks and older patients with favourable factors in haematopoietic stem cell transplantation for adult aplastic aanemia: P1175
10. Genome-wide profiling of structural genomic variations in Korean AML patients: P939
11. Outcome of patients with relapsed or progressive CNS germ cell tumours treated with high-dose chemotherapy followed by autologous stem cell rescue: results of Korean Society of Pediatric Neuro-Oncology-S 053 and 083 trial: P581
12. Conditioning with busulfan and fludarabine for allogeneic haematopoietic stem cell transplantation in children with acute myeloid leukaemia: a comparison to busulfan and cyclophosphamide: P568
13. Risk factors for acute and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in paediatric patients: P498
14. Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset
15. Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome
16. Successful first-line treatment with double umbilical cord blood transplantation in severe aplastic anemia
17. Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children
18. Current status of paediatric umbilical cord blood transplantation in Korea: O146
19. The outcome of DLI in AML/MDS patients relapsed after allogeneic stem cell transplantation: multicentre retrospective study
20. Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma
21. New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
22. Early engraftment kinetics of two units cord blood transplantation
23. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia
24. High-dose chemotherapy with autologous haematopoietic stem cell transplantation in children with poor-risk non-Hodgkin lymphoma: a report from Korean Society of Pediatric Hematology-Oncology
25. Busulfan/cyclophosphamide conditioning followed by autologous stem cell transplantation for acute myeloid leukaemia: retrospective multicentre study
26. STI-571 combined with chemotherapy followed by autologous stem cell transplantation and post-transplant maintenance therapy with STI-571 has relatively good outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukaemia
27. Interim analysis of peripheral blood CD34+ cell on the first day after recovering WBC>1000/microL to predict the collection efficiency of leukapheresis in patients with non-Hodgkin lymphoma and multiple myeloma
28. Unrelated cord blood transplantation with non-myeloablative conditioning regimen in paediatric acute leukaemia
29. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia
30. Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia
31. Successive double high-dose chemotherapy with peripheral blood stem cell rescue collected during a single leukapheresis round in patients with high-risk pediatric solid tumors: a pilot study in a single center
32. Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies
33. Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies
34. Peri-engraftment syndrome in allogeneic hematopoietic SCT
35. Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome
36. Successful first-line treatment with double umbilical cord blood transplantation in severe aplastic anemia
37. Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.